( June 16, 2026, 3:09 PM EDT) -- SEATTLE — Eli Lilly and Co., two medical centers and two of their physicians who prescribe patients compounded versions of tirzepatide XE "tirzepatide" , a U.S. Food and Drug Administration-approved drug for diabetes and weight loss, on June 15 filed a joint stipulation of dismissal after a Washington federal judge again refused to approve a sealed consent judgment and settlement agreement....